Introduction
Isomorphic Labs is an Alphabet company focused on AI-first drug design. Official communications describe applying machine learning advances—including protein structure modeling lineages from DeepMind research—to therapeutic discovery.
Only official Isomorphic Labs sources are used here.
What the company does
AI-first drug design company applying advances in protein structure and related models to therapeutic discovery, per official materials; an Alphabet company.
Who it serves
Pharmaceutical research programs and collaborators in AI-driven drug design.
Company background
United Kingdom
Product and AI capabilities
AI-first drug design company applying advances in protein structure and related models to therapeutic discovery, per official materials; an Alphabet company.
Key developments
Why it matters
Isomorphic Labs connects DeepMind-era protein modeling progress to commercial drug design under Alphabet.
Sector context
See Brel’s Healthcare sector hub for related profiles.
Sources and references
Official: https://www.isomorphiclabs.com